EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The molecular pathology of hemophilia



The molecular pathology of hemophilia



Qjm 63(242): 473-492



The great success of recombinant DNA technology in unravelling the pathology of the thalassaemias at a molecular level has encouraged the application of these methods to other single gene disorders of man in the hope of gaining a deeper insight into the biochemical defects underlying them. An example of this approach is provided by the sex-linked recessive disorders of blood clotting: haemophilia and Christmas disease. These clinically indistinguishable, life-long disorders result from the deficiency or abnormality of the clotting proteins factor VIII and factor IX, respectively, which both participate in the activation of factor X in the intrinsic pathway of blood coagulation. This paper looks at the information concerning the molecular biology and pathology of the haemophilias which has recently been forthcoming. The genes for factor VIII and factor IX have both been successfully cloned within the past five years, with that of factor VIII, achieved in 1984, being a particular tour de force. It encompasses 0.1 per cent of the human X chromosome and is the largest gene yet characterised. Gene cloning is the starting point from which gene probes can be designed to elucidate the molecular pathology of the haemophilias. The implications of these discoveries for the practice of clinical medicine are reviewed, with special emphasis on prenatal diagnosis and carrier detection by means of restriction fragment length polymorphisms, and replacement therapy with recombinant factor VIII.

(PDF 0-2 workdays service: $29.90)

Accession: 006719983

Download citation: RISBibTeXText



Related references

The molecular pathology of hemophilia A. Transfusion Medicine Reviews 5(3): 196-206, 1991

Molecular pathology of hemophilia b. EMBO (European Molecular Biology Organization) Journal 8(4): 1067-1072, 1989

Molecular pathology of hemophilia A. Annals of Hematology 65(SUPPL ): A101, 1992

Molecular pathology in hemophilia A and B, and von Willebrand disease. Cocuk Sagligi ve Hastaliklari Dergisi 36(4): 399-413, 1993

Single-strand conformation polymorphism (SSCP) analysis of the molecular pathology of hemophilia B. Human Mutation 2(5): 355-361, 1993

Molecular biology of hemophilia A and hemophilia B: Present state of DNA diagnosis in Turkey. Cocuk Sagligi ve Hastaliklari Dergisi 38(3): 455-470, 1995

The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project. Progress in Clinical and Biological Research 324: 1-11, 1990

Molecular analysis and genetic diagnosis of hemophilia. b. Hemophilia B. Nihon Rinsho. Japanese Journal of Clinical Medicine 45(12): 2941-2946, 1987

Molecular analysis and genetic diagnosis of hemophilia. a. Hemophilia A. Nihon Rinsho. Japanese Journal of Clinical Medicine 45(12): 2934-2940, 1987

Molecular signatures of lung and pleural tumors: joint symposium of the European Working Groups for Molecular Pathology and Pulmonary Pathology, 21st European Congress of Pathology. Archives of Pathology & Laboratory Medicine 132(10): 1549-1550, 2008

Molecular pathology and immunology of factor VIII (hemophilia A and factor VIII inhibitors). Human Pathology 18(2): 153-161, 1987

Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathologica 122(6): 657-671, 2012

Molecular pathology curriculum for medical laboratory scientists: A report of the association for molecular pathology training and education committee. Journal of Molecular Diagnostics 16(3): 288-296, 2015

The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology. Journal of Molecular Diagnostics 18(5): 605-619, 2016